China Universal Asset Management Co. Ltd. bought a new stake in Stryker Corporation (NYSE: SYK) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 2,000 shares of the medical technology company's stock, valued at approximately $741,000. Other institutional investors have also modified their

Stryker (NYSE: SYK - Get Free Report) and Avivagen (OTCMKTS:VIVXF - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability. Institutional and Insider Ownership 77.1% of Stryker shares are held

Exploring the Strategic Investment Decisions of a Renowned Value Investor Jeff Auxier (Trades, Portfolio) recently submitted the 13F filing for the fourth quar

SYK launches the T2 Alpha Humerus Nailing System to enhance complex fracture care, boosting procedural efficiency and strengthening its trauma portfolio.

Alps Advisors Inc. decreased its position in shares of Stryker Corporation (NYSE: SYK) by 54.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,012 shares of the medical technology company's stock after selling 3,622 shares during the period. Alps Advisors Inc.'s

Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?

PORTAGE, Mich., Feb. 11, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of the T2 Alpha Humerus Nailing System, the latest addition to its T2 Alpha portfolio.

Cibc World Market Inc. lessened its holdings in Stryker Corporation (NYSE: SYK) by 6.3% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 141,032 shares of the medical technology company's stock after selling 9,479 shares during the quarter. Cibc World Market Inc.'s holdings

Advisors Asset Management Inc. increased its stake in shares of Stryker Corporation (NYSE: SYK) by 7.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,644 shares of the medical technology company's stock after acquiring an additional 2,197 shares during

Johnson Investment Counsel Inc. increased its position in Stryker Corporation (NYSE: SYK) by 2.7% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 209,934 shares of the medical technology company's stock after purchasing an additional 5,448 shares during